[if gte mso 9] > < xml >
<!-[if gte mso 10] >
SEDISA and Grünenthal renewed their partnership agreement
Spain, may of 2012- after a year of successful collaboration, SEDISA and Grünenthal renewed its agreement ofcollaboration to continue promoting theproper management of pain in the health system Spanish and increase theawareness of society about this disease.
this consolidated Alliance between the laboratory and the collective of professionals dedicated to themanagement of health, will be reflected in the implementation of conferencesautonomous, and in participation in the 18 national Congress of hospitals thatbe held in Bilbao in the month of February 2013, under the motto creating valuesustainable ’
with all this,Grünenthal will continue betting on working together and encouraging allthose projects that contribute to improving the quality of life of thepatients with pain, in line with the interests and needs of societieshealth-related.
About Grünenthal
the Group Grünenthal is a pharmaceutical companyInternational, independent and family-owned research-basedHeadquartered in Aachen, Germany. Taking advantage of its leading position inthe area of the treatment of pain, its objective is to become the companymore focused on the patient in order to be a leader in therapeutic innovation.
Grünenthal is one of the last five companiespharmaceutical based on research with headquarters in Germany, which invests insustainable way in research and development. This investment amounted toabout 25% of our sales in the year 2011. The strategy ofGrünenthal as regards research and development focuses onSelect specific fields of therapy and the use of the latest technologies.We focus on the intense search for new ways to improve thetreatment of pain, more effective and with fewer adverse reactions.
in total, Grünenthal group has subsidiaries in 26 countries ofworldwide and their products are sold in more than 155. Work approximately4,200 employees in the Grünenthal group around the world, of whichclose of 330 are in the region of Iberia. In 2011, the Grünenthal groupIt reached worldwide an estimated turnover of 947 M €.
on the other hand, Grünenthal Pharma, Spanish subsidiary of the GroupGrünenthal, ranked 9 in the Group of companies of between 250 and 500 employees of the prestigious ranking‘ Best 2009″ Spain 2012 ’,produced by Great Place to Work ®.
About SEDISA
SEDISA is a private and non-profit association ofnon-profit, with legal personality itself, independent of its members,as with full capacity to act to administer and dispose of their propertyand serve the purposes proposed. The purpose of SEDISA consist in therealization of many activities contribute to the promotion, development,protection and defense of health services in general and particularlythe study and improvement of management and executive functions of thehealth, as well as representation, management and advocacyProfessional members.
